Home/Investors/Not Publicly Disclosed

Not Publicly Disclosed

Biotech Investor · 59 portfolio companies

Portfolio
59
Focus Areas
26
Top Stage
preclinical

Portfolio Companies

CompanyValuation
Alchemy
Cambridge Epigenetix
Deep MedChem
Dantari
Poplar Therapeutics
Tasca Therapeutics
SciNeuro Pharmaceuticals
Corner Therapeutics
Red Queen Therapeutics
GeneVax AI
Kimia Therapeutics
ImmunoGen AI
Neurosterix
Dualitas
GC Therapeutics
Ignis Therapeutics
HuidaGene Therapeutics
Kingchem Lifesciences
Kangpu Biopharmaceuticals
Juncell Therapeutics
Huabo Biopharm
HiRo
Hasten Pharma
Deepblue Medical
Metanotitia
Yuhao Chemical
Halda Therapeutics
NeuroHeal AI
Minghui Pharmaceutical
ClonOrgan
Chengdu New Radiomedicine
Baili Pharmaceutical
Anticancer Bioscience
Jiangsu Pacific Meinuoke Biopharmaceuticals
Changzhou Qianhong Bio-pharma
Huateng Pharma
LabInCube
Ruten
Level Nine
MedicQuant
Scinus Cell Expansion
Surf Therapeutics
Q-Lab
Puyi Biotech
Ruoyi Biotech
Nula Therapeutics
Elea & Lili
Virdalis
Excalipoint Therapeutics
Congruence Therapeutics
Entourage AI
iDEL Therapeutics
Connext
Diamens
Celloid
Bochuang Biotechnology
Krishi
Cocuus
Ramona